USA Equities Corp Reports First Quarter 2021 Financial Results and Announces Upcoming Presentation at the University of Miami streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share:
West Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) While the recent and rapid development of Pfizer/BioNTech s COVID-19 vaccine is undoubtedly good news, Time Magazine reported that administering this vaccine to individuals with a history of severe allergic reactions is not recommended, according to a U.K. Regulator, as the United Kingdom is the first country to begin vaccinations. This news comes after two healthcare professionals, both with a history of anaphylactoid reactions, suffered adverse side effects to the vaccine. They have since recovered.
As the United States waits for the vaccine, this news from the U.K. is a cautionary warning. Physicians should begin making preparations ahead of time for those patients with a history of allergic reactions. Despite the uncertainty surrounding this vaccine, physicians can alleviate the patient s worry by providing an allergy test ahead of vaccination. Patients should explore allergy testing ahead of vaccination. Often some